Image of a heart above a cupped hand

Help with insulin is a phone call away.

If you are struggling to pay for insulin and diabetes medication, ADA can help. We’ve consolidated all the resources you need so that you can find help, fast.

Manufacturers are not reporting that COVID-19 is impacting access to insulin and other supplies:

Leading manufacturers are reporting that COVID-19 is not having an impact on their current manufacturing and distribution capabilities for insulin and other supplies at this time. We are continuing to monitor the situation and will provide updates should anything change. If you are struggling to pay for insulin or know someone who is, the ADA has resources to help.

Get Immediate Help From Your Insulin Manufacturer

There are four insulin manufacturers who offer immediate assistance and long-term resources.

This is the fastest way to get help. Be sure to have all of your information ready before you call. Available options are based on your income, insurance, and the type of insulin you need.


In order to find the right support for you, when you call, you may be asked for the following information:

  • Basic contact information
  • Date of birth
  • Income (note: there are supports for all income levels)
  • If you have an active prescription at a pharmacy
  • Cost of insulin for monthly supply and/or amount of deductible
  • Method of insulin administration (via/pen, pump, syringe, inhaled)
  • Dosage
  • How much insulin you have on-hand
  • Type of insurance (private, commercial, Medicare, Medicaid)
  • Whether you are a U.S. resident (required)


Find out who your manufacturer is by checking the company logo on your insulin vial or pen, and call using the numbers provided below.

A customer service representative will confirm your eligibility and explain your options.

Lilly Diabetes Solution Center Logo

Lilly Diabetes Solution Center

Novo Nordisk Diabetes Care Logo

Novo Nordisk NovoCare®

Sanofi Patient Assistance Program Logo

Sanofi Patient Savings Programs

MannKind Support Programs Logo

MannKind Support Programs
Co-Pay Program
Direct Purchase Program

Updated Benefits

  • Reduced out-of-pocket costs: NEW COVID-19 UPDATE: For people with commercial insurance or the uninsured, you can now refill your monthly prescription with a $35 co-pay for most insulins. If you already have a co-pay card from the Lilly Diabetes Solution Center, your co-pay card has been re-set to a $35 co-pay. You can also request additional support if your out-of-pocket cost is higher than $100, call for details.

  • Insulins with lower list prices: Humalog U-100, Humalog Mix75/25, and Humalog Junior KwikPen are available as lower-priced versions (at a 50% discount) and can be ordered through pharmacies within 1-2 business days, if not already available at pharmacies.

  • Immediate supply: If you have an unavoidable need for Lilly insulin, you may qualify for an immediate solution.

  • Donated insulin: Donated Lilly insulins are stocked at nearly 200 free clinics nationwide.

  • Lilly Cares Foundation: A separate non-profit organization that provides free Lilly insulin for eligible patients. Learn more about eligibility criteria at

  • Patient Assistance Program (PAP): NEW COVID-19 UPDATE: This program has been enhanced to provide insulin free of charge for 90 days to eligible participants. Effective April 1, 2020, Medicare patients were no longer required to pay $1,000 for medicines before being eligible for the Novo Nordisk PAP. To be eligible, a person must:

    • Be a US citizen or legal resident.

    • Have a total household income at or below 400% of the federal poverty level (FPL) (See NeedyMeds for a list of the current FPL guidelines) [A family of four with an annual income up to $104,800 may receive free medications through our PAP. For individuals, the annual income limit for participation is $51,040.]

    • Be uninsured, or in the Medicare program.

    • Not be enrolled in or qualify for any other federal, state or government program such as Medicaid, Low Income Subsidy or Veterans (VA) Benefits.

    • Exceptions include patients who are Medicaid eligible who have applied for and been denied Medicaid.

  • My$99Insulin: For $99, people with diabetes can get up to three vials or two packs of FlexPen®/FlexTouch®/PenFill® pens, of any combination of Novo Nordisk Inc. insulins with a prescription.

  • Follow-on brand (also known as authorized generics) insulins: Follow-on brand versions of NovoLog® and NovoLog® Mix, from Novo Nordisk Pharma, Inc. (NNPI), a Novo Nordisk A/S US company, can be ordered at one's local pharmacy, and cost 50 percent off the current list prices of the branded medicines.

  • Immediate Supply: A short-term, immediate-need program for those at risk of rationing while working to identify a longer-term solution. Novo Nordisk may be able to help by providing a free, one-time, immediate supply of up to three vials or two packs of pens of Novo Nordisk Inc. insulin with a prescription.

  • Novo Nordisk human insulin, named ReliOn™, available at Walmart for about $25/vial and for about $44/box of FlexPen®. Similar offerings are found at CVS and other national pharmacies.

  • Copay Savings Cards to help defray the costs for commercially insured patients who are experiencing high out-of-pocket costs. If you have insurance through your employer or private insurance, you may pay as little as $5 per 30-day supply of Tresiba® (maximum savings of $150 per 30-day supply) and/or $25 per 30-day supply of Novolog® (maximum savings up to $100 per 30-day supply) for up to 24 months.

  • NEW updates for 2021: Sanofi is continuing its commitment to ensure affordable access to medications and has now expanded affordable access for its insulin + GLP1RA combination medication Soliqua® 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL and now Toujeo Max SoloStar pen (insulin glargine injection) 300 Units/mL has been added to the Insulins Valyou Savings Program.

  • Co-pay Savings Cards: Eligible commercially insured patients, regardless of income level, can use a co-pay card, which limits out-of-pocket expenses for a majority of patients between $0 to $10. The savings cards for these medications can be accessed in just a few moments after signing up. These programs exist for Adlyxin, Apidra, Lantus, Toujeo, and Soliqua 100/33.

  • Insulin Valyou Savings Program and Soliqua 100/33 Cash Offer: The Insulins Valyou Savings Program is available for all uninsured patients, regardless of income level. Eligible patients can purchase one or multiple Sanofi insulins (Lantus, Toujeo, Admelog, and Apidra) for a fixed price of $99 per month, for up to ten boxes of SoloStar pens and/or 10 mL vials or 5 boxes of Toujeo Max SoloStar pens.


    Similarly, the Soliqua 100/33 cash offer also allows uninsured people to pay $99 per box of pens, for up to two boxes of pens for a 30-day supply. Apply for the Soliqua 100/33 Co-pay card to use this cash offer.

  • Sanofi Patient Connection Patient Assistance Program: Sanofi provides free diabetes medications to qualified low- and middle-income patients through the patient assistance component of the Sanofi Patient Connection program. This program includes all Sanofi diabetes products. Some people facing an unexpected financial hardship may be eligible for a one-time, immediate month’s supply of their Sanofi medicine as they wait for their application to process.


    • Those already participating in the patient assistance program can make an early reorder of their prescription(s) to ensure they have a 90-day supply.

    • Sanofi has expanded acceptable documentation for proof of income to additionally accommodate those experiencing a job loss, furlough, or reduced hours in the pandemic

    • Sanofi has extended the Temporary Patient Assistance Program, which is for patients who meet all the eligibility criteria of the patient assistance program but may be Medicaid eligible and are awaiting a response letter.

    Every patient has unique circumstances, and Sanofi has live support specialists who can be reached at (855) 984-6302 to answer individual patient’s questions and navigate their unique situation to find the best resources and programs to help lower their out-of-pocket costs.

Medical Devices

Below is a list of medical device manufacturers, call the company directly to learn about their patient assistance program.





Eversense CGM






Tandem Diabetes Care


Local Resources

Find low (or no) cost options near you.

Want local support? Find a community health clinic or pharmacy in your area that may offer free or low-cost services and medications.

or visit

More Resources

The following is a list of diabetes medication manufacturers, drug discount programs and health care insurers with special patient assistance.

Note: This is not an exhausted list of companies or programs, many insurers and drug manufacturers have recently launched new patient assistance programs to help with drug costs in response to COVID-19. Call your insurers and diabetes medication manufacturer directly to learn more about cost-saving options.

Benefits Check Up

Info on programs for limited-income seniors

Blink Health

Discounted prices for many medications


Patient Assurance Program helps customers pay less for eligible insulin products.



Discounted prices for medications, info on assistance programs


Database of current medication prices and discounts

Inside Rx

Discounted prices for many medications


Find coupons and other assistance with prescriptions.


Needy Meds

Info on pharmaceutical and healthcare assistance programs

Partnership for Prescription Assistance

Helps people without coverage get medications free or nearly free

Rx Assist

Comprehensive database of pharmaceutical assistance programs

Rx Hope

Helps people get medications free or for a small co-payment


Discounted prices for many medications


Save on glucagon, may pay as little as $0.


Lower-Cost Insulin Formulations

The American Diabetes Association (ADA) recognizes that affordable access to insulin is a matter of life and death, every day for more than 7.5 million Americans with diabetes.

It is important to note that human insulin is not “lower grade.” Rather, it is cheaper than analog insulins because it has been on the market since the 1980s, whereas newer analog insulins were introduced more recently in the mid-1990s.

Human insulin formulations include long-acting insulins like NPH, which has a duration of 8-12 hours, or regular insulin, which has a much quicker onset, as little as 30 minutes, and shorter duration. In select patients with proper monitoring, human insulin may be an option for those who struggle with affording their medications.

In our white paper, published in Diabetes Care, we acknowledge that prescribing patterns have favored newer, more expensive insulins, and acknowledge that human insulin may be an appropriate alternative to more expensive analog insulins for some people with diabetes. We recommend providers “prescribe the lowest-priced insulin required to effectively and safely achieve treatment goals,” which may include using human insulin in selected patients.

We're here for you.

If you're struggling with the cost of insulin, you're not alone. Be sure to talk to your healthcare team to learn about your options.

Visit to find a wealth of resources for living with diabetes or call 1-800-DIABETES (800-342-2383) to speak to an American Diabetes Association representative. They can connect you with appropriate resources in your area and can answer questions in English, Spanish, or any language with a language interpreter service. (Please note that ADA representatives can only answer non-medical questions. If you are need emergency medical service, call 911.)



9am to 5:30pm ET